Magdalena Budisteanu

Magdalena Budisteanu, M.D., PhD., is a medical doctor and researcher specializing in pediatric neurology at "Prof. Dr. Alexandru Obregia” Clinical Hospital of Psychiatry, Bucharest, Romania. Her particular research interests include genetic disorders and autism spectrum disorder.

Education

• 1995, Doctor of Medicine, Faculty Medicine Craiova. Doctor of Philosophy, Faculty Medicine Craiova, Romania
• 2001, PhD in Pediatrics Neurology, Carol Davila University Medicine Bucharest, Romania

EUROMENE

Dr. Budisteanu is a member of the Clinical Research Enablers and Diagnostic Criteria Working Group on behalf of EUROMENE, a European Union COST Action CA15111 not-for-profit research organization committed to tackling the cause and treatment for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

Online presence

• PubMed
• Twitter
• Facebook
• Website

See also

• EUROMENE

Learn more

• Curriculum Vitae
• Victor Babes” National Institute of Pathology (INCDVB) bio

myalgic encephalomyelitis (M.E.) - A disease often marked by neurological symptoms, but fatigue is sometimes a symptom as well. Some diagnostic criteria distinguish it from chronic fatigue syndrome, while other diagnostic criteria consider it to be a synonym for chronic fatigue syndrome. A defining characteristic of ME is post-exertional malaise (PEM), or post-exertional neuroimmune exhaustion (PENE), which is a notable exacerbation of symptoms brought on by small exertions. PEM can last for days or weeks. Symptoms can include cognitive impairments, muscle pain (myalgia), trouble remaining upright (orthostatic intolerance), sleep abnormalities, and gastro-intestinal impairments, among others. An estimated 25% of those suffering from ME are housebound or bedbound. The World Health Organization (WHO) classifies ME as a neurological disease.